CCCC - C4 Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CCCC is currently covered by 3 analysts with an average price target of $7.67. This is a potential upside of $9.33 (118.52%) from yesterday's end of day stock price of $3.51.

C4 Therapeutics 's activity chart (see below) currently has 28 price targets and 32 ratings on display. The stock rating distribution of CCCC is 25% HOLD and 75% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.53% with an average time for these price targets to be met of 57.83 days.

Highest price target for CCCC is $10, Lowest price target is $6, average price target is $7.67.

Most recent stock forecast was given by from BARCLAYS on 27-Feb-2026. First documented stock forecast 27-Oct-2020.

Currently out of the existing stock ratings of CCCC, 1 are a HOLD (25%), 3 are a BUY (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Apr-2022

$7

$2.74 (64.32%)

$20

6 months 18 days ago
(27-Feb-2026)

0/6 (0%)

$4.3 (159.26%)

Buy Since 23-Sep-2025

$10

$5.74 (134.74%)

$12

11 months 22 days ago
(23-Sep-2025)

5/8 (62.5%)

$7.41 (286.10%)

129

Buy Since 22-Sep-2025

$6

$1.74 (40.85%)

$6

11 months 23 days ago
(22-Sep-2025)

1/3 (33.33%)

$3.39 (129.89%)

16

Buy Since 23-Feb-2024

$8

1 years 10 days ago
(04-Sep-2025)

2/7 (28.57%)

$5.44 (212.50%)

119

Buy Since 27-Oct-2020

$14

$11.59 (480.91%)

2 years 6 months 10 days ago
(04-Mar-2024)

1/2 (50%)

$3.32 (31.09%)

29

Show more analysts

Please expand the browser size to see the chart

What is CCCC (C4 Therapeutics ) average time for price targets to be met?

On average it took 58 days for the stock forecasts to be reached, with an average price target met ratio of 42.53%.

Which analyst most recently updated their price target on CCCC (C4 Therapeutics )?

Which analyst has the most public recommendations on CCCC (C4 Therapeutics )?

has 0 price targets and 0 ratings on CCCC

Which analyst is the currently most bullish on CCCC (C4 Therapeutics )?

Leah Rush Cann with the highest potential upside of $76.14

Which analyst is the currently most reserved on CCCC (C4 Therapeutics )?

Bradley Canino with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?